Trial: 201902007

A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving
Intensive Induction Chemotherapy

Phase

II/III

Principal Investigator

Uy, Geoffrey

Disease Site

Acute Myeloid Leukemia (AML); Myeloid and Monocytic Leukemia

Learn more about this study at: clinicaltrials.gov